Keros Therapeutics (KROS) Enterprise Value (2020 - 2026)
Keros Therapeutics (KROS) reported Enterprise Value of -$45.46 million for Q2 2026, compared with -$148 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Enterprise Value (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Keros Therapeutics' Enterprise Value came in at -$1.72 billion; for FY2025, it was $470.41 million, up 473.3% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of -10.7% (FY2020 to FY2025).
- By year, Enterprise Value came in at $82.05 million in FY2024 (-91.2%), $934.85 million in FY2023 (-10.4%), $1.04 billion in FY2022 (-11.0%) and $1.17 billion in FY2021 (+41.6%).
- Five-year quarterly Enterprise Value spans a low of -$307.21 million in Q1 2025 and a high of $1.95 billion in Q1 2024.
- The high point for year-over-year Enterprise Value in five years was Q4 2025 (growth of 473.3%); the low point was Q4 2024 (a decline of 91.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Keros Therapeutics | 221.17 Mn | -1.71 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45.46 Mn |
| Dec 31, 2025 | 470.41 Mn |
| Sep 30, 2025 | -50.67 Mn |
| Jun 30, 2025 | -148.00 Mn |
| Mar 31, 2025 | -307.21 Mn |
| Dec 31, 2024 | 82.05 Mn |
| Sep 30, 2024 | 1.75 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.95 Bn |
| Dec 31, 2023 | 934.85 Mn |
| Sep 30, 2023 | 658.28 Mn |
| Jun 30, 2023 | 869.75 Mn |
| Mar 31, 2023 | 910.30 Mn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 741.60 Mn |
| Jun 30, 2022 | 459.36 Mn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.17 Bn |
| Sep 30, 2021 | 704.23 Mn |
| Jun 30, 2021 | 753.66 Mn |
API Access
Keros Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();